Azilsartan: all 22 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Comparative Effectiveness of Dual Antihypertensive Regimens in Patients After Percutaneous Coronary InterventionRecruitingNCT07683585Not applicable
- A Study of TAK-536 in Children From 2 to Less Than 6 Years Old With High Blood PressureCompletedNCT04668157Phase 3Results posted
- A Phase 1 Food Effect Study of Azilsartan (TAK-536) Pediatric FormulationCompletedNCT03434977Phase 1Results posted
- A Phase 1, Bio-equivalence Study of TAK-536 Pediatric FormulationCompletedNCT03042299Phase 1Results posted
- A Phase 3 Long-term Study of TAK-536 in Pediatric Patients 6 to Less Than 16 Years With HypertensionCompletedNCT02791438Phase 3Results posted
- A Phase 3 Pharmacokinetic Study of TAK-536 (Azilsartan) in Pediatric Patients 6 to Less Than 16 Years With HypertensionCompletedNCT02451150Phase 3Results posted
- A Bioequivalence Study of TAK-536 Pediatric FormulationCompletedNCT02401464Phase 1Results posted
- A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-RCompletedNCT02079805Phase 4Results posted
- Azilsartan Circadian and Sleep PressureCompletedNCT01762501Not applicableResults posted
- Azilsartan in Patients With Diabetic Kidney Disease and HypertensionStatus unknownNCT05753696Not applicable
- A Drug-Drug Interaction Study of CTL0801 and CTL0802 Compared to Coadministration in Healthy Adult VolunteersCompletedNCT05002244Phase 1
- Bioequivalence Study of Azilsartan Tablets in Chinese Healthy VolunteersCompletedNCT03652792Phase 1
- Pharmacokinetics Study of Azilsartan Tablets in Chinese Healthy VolunteersCompletedNCT02786082Phase 1
- Azilsartan in Chinese Patients With Mild and Moderate HypertensionCompletedNCT02609490Phase 3
- Efficacy and Safety of Azilsartan Compared to Olmesartan Medoxomil in Chinese Participants With Grade I or II Essential HypertensionStatus unknownNCT02407210Phase 3
- A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia.WithdrawnNCT02400775Phase 4
- Pleiotropic Effects of Azilsartan Medoxomil Over Insulin Resistance in Obese, Diabetic and Hypertensive PatientsStatus unknownNCT02235519Phase 2/3
- New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure LoweringCompletedNCT01609959Phase 4
- Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential HypertensionCompletedNCT01289132Phase 2
- Efficacy and Safety of Pioglitazone and Azilsartan in Treating Subjects With Type 2 Diabetes MellitusCompletedNCT00762736Phase 2
- Efficacy and Safety of Azilsartan in Subjects With Essential HypertensionCompletedNCT00759551Phase 2
- Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes MellitusTerminatedNCT00376181Phase 3